PDB100 - Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey
dc.contributor.author | Malhan, Berna Simten | |
dc.contributor.author | Güler, Serdar | |
dc.contributor.author | Yetkin, İlhan | |
dc.contributor.author | Baeten, Steef | |
dc.contributor.author | Verheggen, Bram | |
dc.date.accessioned | 2021-11-01T14:58:11Z | |
dc.date.available | 2021-11-01T14:58:11Z | |
dc.date.issued | 2014 | |
dc.department | Hitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | |
dc.description.abstract | Objectives Type 2 diabetes (T2D) patients on basal insulin with uncontrolled HbA1c levels often receive an add-on with bolus insulin to lower HbA1c levels. The aim of this analysis is to estimate long-term cost-effectiveness of treating T2D patients with – a recently introduced – twice daily (BID) exenatide add-on to basal insulin strategy from a Turkish health care perspective. | |
dc.identifier.citation | Malhan, S., Güler, S., Yetkin, I., Baeten, S., & Verheggen, B. (2014). Cost-effectiveness of exenatide twice daily (bid) added to basal insulin compared to a bolus insulin add-on in Turkey. Value in Health, 17(7), A349. | |
dc.identifier.doi | 10.1016/j.jval.2014.08.722 | |
dc.identifier.endpage | A349 | en_US |
dc.identifier.issn | 1098-3015 | |
dc.identifier.issn | 1524-4733 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.pmid | 27200672 | |
dc.identifier.startpage | A349 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jval.2014.08.722 | |
dc.identifier.uri | https://hdl.handle.net/11491/6506 | |
dc.identifier.volume | 17 | en_US |
dc.identifier.wos | WOS:000346917300146 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Güler, Serdar | |
dc.language.iso | en | |
dc.publisher | Elsevier Science Inc | |
dc.relation.ispartof | Value In Health | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | [No Keywords] | en_US |
dc.title | PDB100 - Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey | |
dc.type | Conference Object |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- serdar-guler2014.pdf
- Boyut:
- 62.59 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text